Daily non-political popular news in brief.

Early warning: PSA testing can predict advanced prostate cancer

Researchers find a single test taken before age 50 can aid prostate cancer diagnosis up to 25 years later.

Read more »

Keywords: warning, psa, testing, predict, advanced, prostate, cancer

« Previous | Next »

Similar news on "Early warning: PSA testing can predict advanced prostate cancer":

1. PSA testing can predict advanced prostate cancer
   02-14-2008 · EurekAlert!
   A single prostate specific antigen test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan-Kettering Cancer Center in New York and Lund University in Sweden.
   Similar news · Read more »
   
2. Genes offer researchers a 'crystal ball' to help them prevent, diagnose and treat cancer
   11-12-2006 · EurekAlert!
   The science of cancer prevention has advanced to the point where researchers now say they can detect "cancer genes" in the breath of smokers, and can test the presence of two proteins in men they say will predict development of prostate cancer a decade in advance.
   Similar news · Read more »
   
3. Prostate specific antigen: A review of PSA use in screening for prostate cancer
   06-18-2007 · EurekAlert!
   In this review, Drs. Ian Thompson and Donna Ankerst examine the evidence in support of using prostate specific antigen testing, and then discuss how physicians should advise patients about the merits and drawbacks of the test.
   Similar news · Read more »
   
4. Other highlights in the Dec. 11 JNCI
   12-11-2007 · EurekAlert!
   Also in the Dec. 11 JNCI are a drug that may reduce breast cancer recurrence, the risk of cancer after a blood transfusion, the association between PSA testing and prostate cancer diagnoses, and cancer risk among NBN mutation carriers.
   Similar news · Read more »
   
5. PSA is poor predictor of lethal prostate cancer
   04-03-2007 · EurekAlert!
   The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute.
   Similar news · Read more »
   
6. Using additional biopsy-scoring data may help determine prostate cancer prognosis
   10-02-2007 · EurekAlert!
   Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.
   Similar news · Read more »
   
7. Study first: Over-expression of Cox-2 can predict prostate cancer outcome
   11-08-2006 · EurekAlert!
   Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. That is the result of the first study linking COX-2 with prostate cancer radiation treatment outcomes.
   Similar news · Read more »
   
8. Increased patient demand for prostate test has serious implications for cancer services
   11-16-2006 · EurekAlert!
   A survey of over 700 UK family doctor practices has shown that two-thirds provide PSA testing for prostate cancer on demand, despite lack of evidence that this approach is effective. This represents a major pressure on family doctors and cancer services alike, says the paper in BJU International.
   Similar news · Read more »
   
9. Radiation therapy technique reduces length of prostate cancer treatment
   09-20-2007 · UT Southwestern Medical Center
   Dr. Robert Timmerman is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.
   Similar news · Read more »
   
10. Genetic marker linked to aggressive prostate cancer
    05-20-2007 · EurekAlert!
    Northwestern University researchers have discovered that a recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease. These findings ultimately will aid the development of a simple blood test to predict who is susceptible to this aggressive cancer. Knowing which patients carry this genetic marker also will guide doctors in how they treat the cancer. The study showed a strong hereditary component to this aggressive cancer.
    Similar news · Read more »